RhoA/ROCK signalling activated by ARHGEF3 promotes muscle weakness via autophagy in dystrophic mdx mice
Abstract Background Duchenne muscular dystrophy (DMD), caused by dystrophin deficiency, leads to progressive and fatal muscle weakness through yet‐to‐be‐fully deciphered molecular perturbations. Emerging evidence implicates RhoA/Rho‐associated protein kinase (ROCK) signalling in DMD pathology, yet i...
Main Authors: | Jae‐Sung You, Yongdeok Kim, Soohyun Lee, Rashid Bashir, Jie Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Journal of Cachexia, Sarcopenia and Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1002/jcsm.13278 |
Similar Items
-
Role of ARHGEF3 as a GEF and mTORC2 Regulator
by: Sana Abdul Khaliq, et al.
Published: (2022-01-01) -
l-arginine improves dystrophic phenotype in mdx mice
by: Vincent Voisin, et al.
Published: (2005-10-01) -
Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle
by: William J. Valentine, et al.
Published: (2022-01-01) -
Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology
by: Daniel P. Reay, et al.
Published: (2011-09-01) -
Indicators of increased ER stress and UPR in aged D2-mdx and human dystrophic skeletal muscles
by: Swathy Krishna, et al.
Published: (2023-04-01)